Hospital Strategies to Address Non-Adherence to Guideline-Recommended Dual Antiplatelet Therapy After Myocardial Infarction: Findings From the Affordability and Real-World Antiplatelet Treatment Effectiveness After Myocardial Infarction Study (ARTEMIS)

被引:0
|
作者
Wang, Tracy
McCoy, Lisa A.
Choudhry, Niteesh K.
Henry, Timothy D.
Cannon, Christopher P.
Fonarow, Gregg C.
Doll, Jacob A.
Cohen, David J.
Bhandary, Durgesh D.
Khan, Naeem
Anstrom, Kevin J.
Peterson, Eric D.
机构
关键词
Adherence; Myocardial infarction; Dual antiplatelet; Outcomes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
15002
引用
收藏
页数:3
相关论文
共 40 条
  • [31] Refusal of prescribed drug therapy (absolute non-adherence) after acute myocardial infarction/unstable angina: data from prospective observation in the LIS-3 registry
    Yu, Martsevich S.
    Zolotareva, N. P.
    Zagrebelnyy, A., V
    Kutishenko, N. P.
    Lukina, Yu, V
    Ginzburg, M. L.
    Drapkina, O. M.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (06) : 572 - 578
  • [32] Individual long-term variation of platelet reactivity in patients with dual antiplatelet therapy after myocardial infarction: Results from Assessing Platelet Activity in Coronary Heart Disease (APACHE)
    Alfredsson, Joakim
    Swahn, Eva
    Gustafsson, Kerstin M.
    Janzon, Magnus
    Jonasson, Lena
    Logander, Elisabeth
    Nilsson, Lennart
    Lindahl, Tomas L.
    PLATELETS, 2019, 30 (05) : 572 - 578
  • [33] All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study
    Degli Esposti, Luca
    Perrone, Valentina
    Veronesi, Chiara
    Buda, Stefano
    Rossini, Roberta
    VASCULAR HEALTH AND RISK MANAGEMENT, 2018, 14 : 383 - 392
  • [34] Dual antiplatelet and oral anticoagulant treatment of patients discharged after PCI in acute myocardial infarction - current clinical practice and 12-month outcome - analysis from the PL-ACS Registry
    Gierlotka, M.
    Kuliczkowski, W.
    Gasior, M.
    Hawranek, M.
    Tajstra, M.
    Wilczek, K.
    Kalarus, Z.
    Olszowski, D.
    Ostrega, M.
    Polonski, L.
    EUROPEAN HEART JOURNAL, 2012, 33 : 312 - 312
  • [35] Impact of statin adherence and interruption within 6 months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI
    Giacobbe, Federico
    Giannino, Giuseppe
    Annone, Umberto
    Morena, Arianna
    Di Vita, Umberto
    Carmagnola, Ludovica
    Nebiolo, Marco
    Rollo, Cesare
    Ravetti, Emanuele
    Troncone, Mattia
    Pancotti, Corrado
    De Filippo, Ovidio
    Bruno, Francesco
    Angelini, Filippo
    Gaido, Luca
    Fariselli, Piero
    D'Ascenzo, Fabrizio
    Giammaria, Massimo
    De Ferrari, Gaetano Maria
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 405
  • [36] Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial
    Kedhi, Elvin
    Fabris, Enrico
    van der Ent, Martin
    Buszman, Pawel
    von Birgelen, Clemens
    Roolvink, Vincent
    Zurakowski, Alexander
    Schotborgh, Carl E.
    Hoorntje, Jan C. A.
    Eek, Christian Hasbo
    Cook, Stephane
    Togni, Marco
    Meuwissen, Martijn
    van Royen, Niels
    van Vliet, Ria
    Wedel, Hans
    Delewi, Ronak
    Zijlstra, Felix
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [37] Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study
    Fanaroff, Alexander C.
    Kaltenbach, Lisa A.
    Peterson, Eric D.
    Akhter, Mohammed W.
    Effron, Mark B.
    Henry, Timothy D.
    Wang, Tracy Y.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (04):
  • [38] Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy
    Kirchmayer, U.
    Agabiti, N.
    Belleudi, V.
    Davoli, M.
    Fusco, D.
    Stafoggia, M.
    Arca, M.
    Barone, A. P.
    Perucci, C. A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (01) : 37 - 44
  • [39] Real World Analysis from the "Fast STEMI" Registry on Adherence and Discontinuation of Statin Therapy Within 6 Months After ST-Elevation Myocardial Infarction on First Year Follow-Up: Prognostic Impact and Predictors of Adherence
    Morena, Arianna
    Giacobbe, Federico
    Annone, Umberto
    Ravetti, Emanuele
    di Vita, Umberto
    Giannino, Giuseppe
    Troncone, Mattia
    Carmagnola, Ludovica
    Dusi, Veronica
    CIRCULATION, 2023, 148
  • [40] Use of and in hospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: Results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE)
    Alexander, Deepu
    On, Fang-Shu
    Roe, Matthew T.
    Pollack, Charles V.
    Ohman, E. Magnus
    Cannon, Christopher P.
    Gibler, W. Brian
    Fintel, Dan J.
    Peterson, Eric D.
    Brown, David L.
    AMERICAN HEART JOURNAL, 2008, 156 (03) : 606 - 612